On Invalid Date, Atyr Pharma (NASDAQ: LIFE) reported Q3 2023 earnings per share (EPS) of -$0.20, up 56.52% year over year. Total Atyr Pharma earnings for the quarter were -$11.34 million. In the same quarter last year, Atyr Pharma's earnings per share (EPS) was -$0.46.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.